Senior insider sale
See Remarks at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$28.30M
398.06K shares
KUMAR NEIL plans to sell 398.06K shares of BRIDGEBIO PHARMA, INC. valued at approximately $28.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Conversion Management Incentive Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2016 | Conversion Management Incentive Units N/A | 140K | — |
| Total | 140K | ||
Completed
Units to sell
20K
Market value
$1.37M
Units to sell
20K
Market value
$1.37M
Units to sell
28.05K
Market value
$2.00M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.54M
Units to sell
20K
Market value
$1.54M
Units to sell
20K
Market value
$1.48M
Units to sell
20K
Market value
$1.48M
Units to sell
30.01K
Market value
$2.24M
Planned — Approximate Date
Units to sell
140K
Market value
$9.52M
Units
398.06K
Value
$28.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/12/2026 | 20K | $1.37M | — | Completed |
3/12/2026 | 20K | $1.37M | — | Completed |
2/19/2026 | 28.05K | $2.00M | — | Completed |
2/11/2026 | 20K | $1.44M | — | Completed |
2/11/2026 | 20K | $1.44M | — | Completed |
2/10/2026 | 20K | $1.44M | — | Completed |
2/10/2026 | 20K | $1.44M | — | Completed |
1/9/2026 | 20K | $1.54M | — | Completed |
1/9/2026 | 20K | $1.54M | — | Completed |
1/8/2026 | 20K | $1.48M | — | Completed |
1/8/2026 | 20K | $1.48M | — | Completed |
12/15/2025 | 30.01K | $2.24M | — | Completed |
| Planned — Approximate Date | ||||
3/13/2026 | 140K | $9.52M | NASDAQ | Planned |
| Total | 398.06K | $28.30M | ||